Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment

[1]  Katsutoshi Takahashi,et al.  Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism , 2022, Hypertension Research.

[2]  H. Rakugi,et al.  Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism. , 2020, Hypertension.

[3]  Yoshihiko Kanno,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) , 2019, Hypertension Research.

[4]  Katsutoshi Takahashi,et al.  High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan , 2019, Diabetes Care.

[5]  C. Zoccali,et al.  Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term , 2018, Hypertension.

[6]  F. Veglio,et al.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. , 2017, Journal of the American College of Cardiology.

[7]  P. Chambon,et al.  Direct Regulation of Blood Pressure by Smooth Muscle Cell Mineralocorticoid Receptors , 2012, Nature Medicine.

[8]  M. Bazzocchi,et al.  Intrarenal hemodynamics in primary aldosteronism before and after treatment. , 2009, Journal of Clinical Endocrinology and Metabolism.

[9]  D. Rizzoni,et al.  Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.

[10]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[11]  J. Laragh,et al.  Renin relationship to sex, race and age in a normotensive population. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[12]  J. Hall,et al.  The renin-angiotensin system and long-term regulation of arterial pressure. , 1986, Journal of hypertension.

[13]  J. Conn.  PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION. , 1964, JAMA.

[14]  T. Diperri,et al.  Aldosterone in congestive heart failure. , 1959, Acta medica Scandinavica.

[15]  M. Reincke.  Anxiety, Depression, and Impaired Quality of Life in Primary Aldosteronism: Why We Shouldn't Ignore It! , 2018, The Journal of clinical endocrinology and metabolism.

[16]  G. Curhan,et al.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.

[17]  L. S. Schultze Kool,et al.  Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment , 2018, The Journal of clinical endocrinology and metabolism.

[18]  Fiorenzo Gaita,et al.  Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.

[19]  K. Shimamoto.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) , 2014 .

[20]  R. Vasan,et al.  Age as a risk factor. , 2012, The Medical clinics of North America.

[21]  W. Haynes,et al.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications , 2012, Hypertension Research.